Kura Oncology Grants Options for 55,500 Shares to Three New Employees

• Kura Oncology granted nonstatutory stock options covering 55,500 common shares to three new employees on November 2, 2026.
• The awards fall under the amended 2023 Inducement Option Plan, with vesting over four years.
• Vesting begins with 25% on the first anniversary of the applicable commencement date; the remainder vests monthly over 36 months, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060730PRIMZONEFULLFEED9871990) on November 06, 2026, and is solely responsible for the information contained therein.